Equillium, Inc. - 8-K Filing
Equillium reports Q3 2026 net loss of $4.6 million and announces $20 million in new financing following EQ504 Phase 1 trial initiation. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)